Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia

Cerdeira, AS; O'Sullivan, J; Ohuma, EO; James, T; Papageorghiou, AT; Knight, M; Vatish, M

Journal article : Letter

Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Cerdeira, A. S., O'Sullivan, J., Ohuma, E. O., James, T., Papageorghiou, A. T., Knight, M., & Vatish, M. (2021). Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia. American Journal of Obstetrics and Gynecology.

MLA Style

Cerdeira, A. S., et al. “Ruling out Preeclampsia in the next 4 Weeks Using a Soluble Fms-like Tyrosine Kinase 1/Placental Growth Factor Ratio ≤38: Secondary Analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia.” American Journal of Obstetrics and Gynecology, Elsevier, 2021.

Chicago Style

Cerdeira, AS, J O'Sullivan, EO Ohuma, T James, AT Papageorghiou, M Knight, and M Vatish. 2021. “Ruling out Preeclampsia in the next 4 Weeks Using a Soluble Fms-like Tyrosine Kinase 1/Placental Growth Factor Ratio ≤38: Secondary Analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women With Suspected Preeclampsia.” American Journal of Obstetrics and Gynecology.
Share
Print